Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial

[1]  Eyal Dassau,et al.  International Consensus on Use of Continuous Glucose Monitoring , 2017, Diabetes Care.

[2]  Bruce W Bode,et al.  Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. , 2017, The lancet. Diabetes & endocrinology.

[3]  A. Kotwal,et al.  Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes , 2017, Journal of diabetes research.

[4]  W. Tamborlane,et al.  Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study , 2017, Diabetes Care.

[5]  Howard Wolpert,et al.  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial , 2017, JAMA.

[6]  Sofia Dahlqvist,et al.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial , 2017, JAMA.

[7]  IN CONTROL of type 1 diabetes, despite hypoglycaemia unawareness. , 2016 .

[8]  J. DeVries,et al.  Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. , 2016, The lancet. Diabetes & endocrinology.

[9]  L. Laffel.  Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. , 2016, Diabetes technology & therapeutics.

[10]  P. Choudhary,et al.  Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient—An Evidence-based Approach , 2015, Current Diabetes Reports.

[11]  H. PolonskyWilliam,et al.  Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life , 2015 .

[12]  L. Strycker,et al.  Understanding the sources of diabetes distress in adults with type 1 diabetes. , 2015, Journal of diabetes and its complications.

[13]  L. Heinemann,et al.  HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections. , 2015, Journal of diabetes science and technology.

[14]  B. Frier.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications , 2014, Nature Reviews Endocrinology.

[15]  S. Heller,et al.  Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 × 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS) , 2014, Diabetes Care.

[16]  T. Jones,et al.  Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. , 2013, JAMA.

[17]  B. Olsen,et al.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial , 2012, Diabetologia.

[18]  E. Bass,et al.  Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus , 2012, Annals of Internal Medicine.

[19]  J. Pickup,et al.  Insulin-pump therapy for type 1 diabetes mellitus. , 2012, The New England journal of medicine.

[20]  Alex J Sutton,et al.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.

[21]  Bruce A Buckingham,et al.  Outcome Measures for Outpatient Hypoglycemia Prevention Studies , 2011, Journal of diabetes science and technology.

[22]  M. Phillip,et al.  Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.

[23]  D. Cox,et al.  Psychometric Properties of the Hypoglycemia Fear Survey-II for Adults With Type 1 Diabetes , 2011, Diabetes Care.

[24]  B. Frier,et al.  Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[25]  W. Greiner,et al.  Validating the EQ-5D with time trade off for the German population , 2005, The European Journal of Health Economics.

[26]  B P Kovatchev,et al.  Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. , 1998, Diabetes care.

[27]  Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans , 1998, Diabetologia.

[28]  D. Cox,et al.  Reduced Awareness of Hypoglycemia in Adults With IDDM: A prospective study of hypoglycemic frequency and associated symptoms , 1995, Diabetes Care.